Medistep Health.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Diversified consumer products
  • ISIN: INE0UOY01019
  • NSEID: MEDISTEP
  • BSEID:
INR
22.90
0.1 (0.44%)
BSENSE

Sep 04, 03:30 PM

BSE+NSE Vol: 12000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 42.65% vs 57.06% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 47.18% vs 41.58% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 491.30% vs -26.80% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 44.38% vs 42.23% in Mar 2025

Compare Profit and Loss Results of Medistep Health.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
70.00
30.00
40.00
133.33%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
70.00
30.00
40.00
133.33%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
0.00
-4.00
0%
Raw Materials Consumed
66.00
13.00
53.00
407.69%
Power & Fuel Cost
0.00
2.00
-2.00
-100.00%
Employee Cost
0.00
7.00
-7.00
-100.00%
Operating Expenses
0.00
3.00
-3.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
2.00
-2.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
62.00
30.00
32.00
106.67%
Operating Profit (PBDIT) excl Other Income
8.00
0.00
8.00
0%
Other Income
0.00
4.00
-4.00
-100.00%
Operating Profit (PBDIT)
8.00
4.00
4.00
100.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
8.00
3.00
5.00
166.67%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
7.00
1.00
6.00
600.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
7.00
1.00
6.00
600.00%
Provision for Tax
2.00
0.00
2.00
0%
Profit After Tax
5.00
0.00
5.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
6.00
29.00
-23.00
-79.31%
Profit Available for appropriations
12.00
30.00
-18.00
-60.00%
Appropriations
12.00
30.00
-18.00
-60.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.68
0.84
3.84
457.14%
Profit And Loss - Net Sales
Net Sales 70.83 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 42.65% vs 57.06% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 47.18% vs 41.58% in Mar 2025

Profit And Loss - Interest
Interest 0.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 491.30% vs -26.80% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 5.98 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 44.38% vs 42.23% in Mar 2025